Chronic lymphocytic leukemia (CLL) is the most prevalent lymphoproliferative disorder in the United States and Europe and is characterized by the clonal expansion of mature CD5+ CD23+ B cells  (1, 2). Here, CD5 is linked to B-cell chronic lymphocytic leukemia.